InsiderTrades.com logo

ARWR Insider Trading

Insider Ownership Percentage: 3.60%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $36,959,695.02

Arrowhead Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Arrowhead Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Arrowhead Pharmaceuticals Share Price & Price History

Current Price: $56.33
Price Change: ▼ Price Decrease of -0.63 (-1.11%)
As of 03/20/2026 05:00 PM ET

This chart shows the closing price history over time for ARWR up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Arrowhead Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/5/2026James C. HamiltonInsiderSell10,000$64.19$641,900.00236,958View SEC Filing Icon  
1/5/2026James C. HamiltonInsiderSell40,164$63.11$2,534,750.04171,958View SEC Filing Icon  
1/5/2026Patrick C. O'BrienCOOSell49,493$63.11$3,123,503.23474,908View SEC Filing Icon  
1/2/2026Christopher Richard AnzaloneCEOSell13,187$66.10$871,660.703,792,739View SEC Filing Icon  
12/29/2025Christopher Richard AnzaloneCEOSell51,726$69.13$3,575,818.383,805,926View SEC Filing Icon  
12/26/2025Mauro FerrariDirectorSell7,530$70.00$527,100.0069,053View SEC Filing Icon  
12/22/2025Christopher Richard AnzaloneCEOSell12,586$68.44$861,385.843,805,926View SEC Filing Icon  
12/19/2025Adeoye Y. OlukotunDirectorSell10,000$67.66$676,600.0033,600View SEC Filing Icon  
12/19/2025Christopher Richard AnzaloneCEOSell13,445$67.66$909,688.703,818,512View SEC Filing Icon  
12/19/2025Victoria VakienerDirectorSell10,040$67.68$679,507.2035,723View SEC Filing Icon  
12/19/2025William D. WaddillDirectorSell8,367$67.65$566,027.5556,563View SEC Filing Icon  
12/17/2025Christopher Richard AnzaloneCEOSell85,000$64.04$5,443,400.003,831,957View SEC Filing Icon  
12/16/2025Christopher Richard AnzaloneCEOSell54,298$62.58$3,397,968.843,916,957View SEC Filing Icon  
12/15/2025Christopher Richard AnzaloneCEOSell130,000$68.85$8,950,500.003,971,255View SEC Filing Icon  
12/5/2025Michael S PerryDirectorSell16,250$61.03$991,737.50115,240View SEC Filing Icon  
11/28/2025Mauro FerrariDirectorSell8,750$56.39$493,412.5068,764View SEC Filing Icon  
10/1/2025James C. HamiltonInsiderSell20,000$35.00$700,000.00212,122View SEC Filing Icon  
9/12/2025James C. HamiltonInsiderSell15,000$30.00$450,000.00232,122View SEC Filing Icon  
9/2/2025James C. HamiltonInsiderSell15,000$25.00$375,000.00247,122View SEC Filing Icon  
8/15/2025James C. HamiltonInsiderSell9,389$20.00$187,780.00262,122View SEC Filing Icon  
8/13/2025James C. HamiltonInsiderSell611$20.00$12,220.00271,511View SEC Filing Icon  
4/11/2025Christopher Richard AnzaloneCEOSell50,800$11.49$583,692.003,921,255View SEC Filing Icon  
4/9/2025Christopher Richard AnzaloneCEOSell40,322$10.07$406,042.544,022,055View SEC Filing Icon  
3/13/2025Christopher Richard AnzaloneCEOSell51,425$15.07$774,974.754,062,377View SEC Filing Icon  
3/4/2025Christopher Richard AnzaloneCEOSell133,333$17.02$2,269,327.663,773,802View SEC Filing Icon  
1/23/2025Adeoye Y. OlukotunDirectorSell959$21.00$20,139.0035,781View SEC Filing Icon  
1/6/2025James C. HamiltonInsiderSell32,729$19.82$648,688.78272,122View SEC Filing Icon  
1/6/2025Kenneth Allen MyszkowskiCFOSell27,167$19.83$538,721.61473,433View SEC Filing Icon  
1/6/2025Patrick C. O'BrienCOOSell29,184$19.82$578,426.88535,201View SEC Filing Icon  
1/2/2025Christopher Richard AnzaloneCEOSell11,520$19.05$219,456.003,764,252View SEC Filing Icon  
12/27/2024Adeoye Y. OlukotunDirectorSell2,850$20.00$57,000.0036,740View SEC Filing Icon  
12/23/2024Christopher Richard AnzaloneCEOSell12,563$19.59$246,109.173,775,772View SEC Filing Icon  
12/18/2024Christopher Richard AnzaloneCEOSell26,712$21.24$567,362.883,688,335View SEC Filing Icon  
12/16/2024William D. WaddillDirectorSell3,748$21.90$82,081.2044,125View SEC Filing Icon  
7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32127,107View SEC Filing Icon  
5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.6930,205View SEC Filing Icon  
3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.0033,680View SEC Filing Icon  
3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.0031,680View SEC Filing Icon  
3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00400,600View SEC Filing Icon  
1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.653,715,048View SEC Filing Icon  
1/12/2024James C. HamiltonInsiderSell7,940$36.89$292,906.60210,851View SEC Filing Icon  
1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66129,711View SEC Filing Icon  
1/5/2024James C. HamiltonInsiderSell32,143$35.18$1,130,790.74218,791View SEC Filing Icon  
1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08440,600View SEC Filing Icon  
1/5/2024Patrick C. O'BrienCOOSell22,841$35.27$805,602.07464,385View SEC Filing Icon  
1/3/2024James C. HamiltonInsiderSell6,300$32.19$202,797.00175,934View SEC Filing Icon  
1/3/2024Patrick C. O'BrienCOOSell8,749$32.28$282,417.72403,826View SEC Filing Icon  
1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.523,715,048View SEC Filing Icon  
12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.003,725,000View SEC Filing Icon  
11/20/2023Javier San MartinInsiderSell19,700$28.80$567,360.00131,800View SEC Filing Icon  
10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.983,737,000View SEC Filing Icon  
9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.5021,734View SEC Filing Icon  
9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.603,761,338View SEC Filing Icon  
7/3/2023Tracie OliverInsiderSell8,925$35.31$315,141.7561,575View SEC Filing Icon  
6/30/2023James C. HamiltonInsiderSell3,000$35.53$106,590.00188,484View SEC Filing Icon  
6/27/2023Kenneth Allen MyszkowskiCFOSell15,000$36.20$543,000.00381,704View SEC Filing Icon  
5/5/2023Douglas B GivenDirectorSell6,500$40.90$265,850.00117,635View SEC Filing Icon  
5/3/2023Christopher Richard AnzaloneCEOSell54,928$39.14$2,149,881.923,761,338View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Arrowhead Pharmaceuticals (NASDAQ:ARWR)

62.61% of Arrowhead Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ARWR by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Arrowhead Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
3/17/2026Rockefeller Capital Management L.P.557$37K0.0%-37.4%0.000%Search for SEC Filing on Google Icon
3/13/2026World Investment Advisors10,987$0.73M0.0%-20.3%0.008%Search for SEC Filing on Google Icon
3/9/2026Corient Private Wealth LLC18,226$1.21M0.0%+3.1%0.013%Search for SEC Filing on Google Icon
3/3/2026Bank of Hawaii19,218$1.28M0.1%N/A0.014%Search for SEC Filing on Google Icon
2/19/2026Invesco Ltd.547,758$36.37M0.0%+8.9%0.391%Search for SEC Filing on Google Icon
2/19/2026Corient Private Wealth LLC18,226$1.21M0.0%+3.1%0.013%Search for SEC Filing on Google Icon
2/18/2026Mercer Global Advisors Inc. ADV5,300$0.35M0.0%N/A0.004%Search for SEC Filing on Google Icon
2/18/2026Summit Global Investments14,287$0.95M0.1%+43.8%0.010%Search for SEC Filing on Google Icon
2/18/2026State of Tennessee Department of Treasury55,642$3.86M0.0%+2.0%0.040%Search for SEC Filing on Google Icon
2/18/2026EP Wealth Advisors LLC38,683$2.57M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/18/2026Mackenzie Financial Corp11,445$0.77M0.0%+12.5%0.008%Search for SEC Filing on Google Icon
2/18/2026Empowered Funds LLC18,018$1.20M0.0%+4.5%0.013%Search for SEC Filing on Google Icon
2/18/2026Voloridge Investment Management LLC288,511$19.15M0.1%-28.3%0.206%Search for SEC Filing on Google Icon
2/18/2026VestGen Advisors LLC12,312$0.82M0.0%N/A0.009%Search for SEC Filing on Google Icon
2/18/2026Vestal Point Capital LP900,000$59.75M2.0%N/A0.643%Search for SEC Filing on Google Icon
2/18/2026Virtus Investment Advisers LLC9,749$0.65M0.2%+39.0%0.007%Search for SEC Filing on Google Icon
2/18/2026Wellington Management Group LLP47,473$3.15M0.0%-4.0%0.034%Search for SEC Filing on Google Icon
2/18/2026RTW Investments LP584,716$38.82M0.4%N/A0.418%Search for SEC Filing on Google Icon
2/18/2026Oxford Asset Management LLP16,026$1.06M0.4%+11.3%0.011%Search for SEC Filing on Google Icon
2/18/2026Millennium Management LLC45,018$2.99M0.0%-59.0%0.032%Search for SEC Filing on Google Icon
2/18/2026Man Group plc11,552$0.77M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/18/2026Janus Henderson Group PLC1,280,446$85M0.0%+31.5%0.914%Search for SEC Filing on Google Icon
2/18/2026Gotham Asset Management LLC56,273$3.74M0.0%+76.6%0.040%Search for SEC Filing on Google Icon
2/18/2026Engineers Gate Manager LP19,772$1.31M0.0%N/A0.014%Search for SEC Filing on Google Icon
2/18/2026Cinctive Capital Management LP16,110$1.07M0.1%N/A0.012%Search for SEC Filing on Google Icon
2/18/2026Balyasny Asset Management L.P.376,216$24.98M0.0%-52.6%0.269%Search for SEC Filing on Google Icon
2/18/2026Baker BROS. Advisors LP2,175,645$144.44M0.8%+30.2%1.554%Search for SEC Filing on Google Icon
2/18/2026Boothbay Fund Management LLC40,504$2.69M0.0%-51.4%0.029%Search for SEC Filing on Google Icon
2/18/2026ACT Capital Management LLC75,000$4.98M4.0%N/A0.054%Search for SEC Filing on Google Icon
2/17/2026Guggenheim Capital LLC56,644$3.76M0.0%+40.3%0.040%Search for SEC Filing on Google Icon
2/17/2026ADAR1 Capital Management LLC58,200$3.86M0.3%+16.9%0.042%Search for SEC Filing on Google Icon
2/17/2026Schonfeld Strategic Advisors LLC20,105$1.34M0.0%-96.3%0.014%Search for SEC Filing on Google Icon
2/17/2026PDT Partners LLC70,048$4.65M0.3%-22.9%0.050%Search for SEC Filing on Google Icon
2/17/2026AQR Capital Management LLC147,353$9.78M0.0%+3.2%0.105%Search for SEC Filing on Google Icon
2/17/2026Abel Hall LLC8,819$0.59M0.1%N/A0.006%Search for SEC Filing on Google Icon
2/17/2026Cetera Investment Advisers6,697$0.45M0.0%N/A0.005%Search for SEC Filing on Google Icon
2/17/2026Trexquant Investment LP250,944$16.66M0.1%N/A0.179%Search for SEC Filing on Google Icon
2/17/2026Amundi26,390$1.75M0.0%-6.3%0.019%Search for SEC Filing on Google Icon
2/17/2026Price T Rowe Associates Inc. MD838,818$55.69M0.0%+660.9%0.599%Search for SEC Filing on Google Icon
2/17/2026Weiss Asset Management LP111,375$7.39M0.1%N/A0.080%Search for SEC Filing on Google Icon
2/17/2026Osaic Holdings Inc.13,340$0.89M0.0%-77.1%0.010%Search for SEC Filing on Google Icon
2/17/2026Integral Health Asset Management LLC100,000$6.64M0.3%-55.6%0.071%Search for SEC Filing on Google Icon
2/17/2026Adage Capital Partners GP L.L.C.550,000$36.51M0.1%N/A0.393%Search for SEC Filing on Google Icon
2/17/2026California State Teachers Retirement System118,372$7.86M0.0%+13.8%0.085%Search for SEC Filing on Google Icon
2/17/2026Russell Investments Group Ltd.122,115$8.11M0.0%+847.8%0.087%Search for SEC Filing on Google Icon
2/17/2026Maryland State Retirement & Pension System20,241$1.34M0.0%+1.8%0.014%Search for SEC Filing on Google Icon
2/17/2026State of Wisconsin Investment Board79,214$5.26M0.0%+22.1%0.057%Search for SEC Filing on Google Icon
2/17/2026Captrust Financial Advisors17,644$1.17M0.0%-11.0%0.013%Search for SEC Filing on Google Icon
2/17/2026Fred Alger Management LLC1,832,997$121.69M0.5%+497.4%1.309%Search for SEC Filing on Google Icon
2/17/2026Avoro Capital Advisors LLC10,625,000$705.39M6.8%-2.5%7.588%Search for SEC Filing on Google Icon
2/17/2026ExodusPoint Capital Management LP42,011$2.79M0.0%-72.4%0.030%Search for SEC Filing on Google Icon
2/17/2026Royal Bank of Canada51,196$3.40M0.0%+25.8%0.037%Search for SEC Filing on Google Icon
2/17/2026Graham Capital Management L.P.4,209$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/17/2026Magnetar Financial LLC39,901$2.65M0.0%N/A0.028%Search for SEC Filing on Google Icon
2/16/2026Vanguard Personalized Indexing Management LLC9,154$0.61M0.0%+10.0%0.007%Search for SEC Filing on Google Icon
2/16/2026Panagora Asset Management Inc.35,955$2.39M0.0%N/A0.026%Search for SEC Filing on Google Icon
2/16/2026Fieldview Capital Management LLC31,665$2.10M0.4%N/A0.023%Search for SEC Filing on Google Icon
2/16/2026Eventide Asset Management LLC370,000$24.56M0.4%N/A0.264%Search for SEC Filing on Google Icon
2/16/2026Entropy Technologies LP27,139$1.80M0.1%+159.1%0.019%Search for SEC Filing on Google Icon
2/16/2026Barclays PLC321,833$21.37M0.0%-8.1%0.230%Search for SEC Filing on Google Icon
2/16/2026Arrowstreet Capital Limited Partnership2,087,953$138.62M0.1%+0.3%1.491%Search for SEC Filing on Google Icon
2/13/2026Kestra Advisory Services LLC2,175$0.14M0.0%N/A0.002%Search for SEC Filing on Google Icon
2/13/2026FORA Capital LLC11,000$0.73M0.1%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Marshall Wace LLP123,855$8.22M0.0%-91.4%0.088%Search for SEC Filing on Google Icon
2/13/2026The Manufacturers Life Insurance Company 98,151$6.55M0.0%+55.8%0.070%Search for SEC Filing on Google Icon
2/13/2026Johnson Investment Counsel Inc.6,000$0.40M0.0%-73.5%0.004%Search for SEC Filing on Google Icon
2/13/2026CANADA LIFE ASSURANCE Co118,750$7.88M0.0%-8.6%0.085%Search for SEC Filing on Google Icon
2/13/2026Affinity Asset Advisors LLC70,000$4.65M0.3%N/A0.050%Search for SEC Filing on Google Icon
2/13/2026Bridgewater Associates LP59,966$3.98M0.0%N/A0.043%Search for SEC Filing on Google Icon
2/13/2026Stifel Financial Corp11,811$0.78M0.0%N/A0.008%Search for SEC Filing on Google Icon
2/13/2026Smartleaf Asset Management LLC2,903$0.20M0.0%+71.6%0.002%Search for SEC Filing on Google Icon
2/13/2026Exome Asset Management LLC49,758$3.30M1.6%-52.4%0.036%Search for SEC Filing on Google Icon
2/13/2026Morgan Stanley1,476,005$97.99M0.0%-13.3%1.054%Search for SEC Filing on Google Icon
2/13/2026Public Sector Pension Investment Board478,514$31.77M0.1%-11.3%0.342%Search for SEC Filing on Google Icon
2/13/2026Rafferty Asset Management LLC84,469$5.61M0.0%-26.1%0.060%Search for SEC Filing on Google Icon
2/13/2026First Trust Advisors LP237,730$15.78M0.0%+14.3%0.170%Search for SEC Filing on Google Icon
2/13/2026Alyeska Investment Group L.P.375,371$24.92M0.1%N/A0.268%Search for SEC Filing on Google Icon
2/13/2026Siren L.L.C.1,500,476$99.62M3.0%-43.8%1.072%Search for SEC Filing on Google Icon
2/13/2026Charles Schwab Investment Management Inc.1,353,719$89.87M0.0%+0.6%0.967%Search for SEC Filing on Google Icon
2/13/2026Police & Firemen s Retirement System of New Jersey35,619$2.37M0.0%+4.7%0.025%Search for SEC Filing on Google Icon
2/13/2026Van ECK Associates Corp6,437$0.43M0.0%+102.7%0.005%Search for SEC Filing on Google Icon
2/13/2026State Street Corp6,403,830$425.15M0.0%+0.1%4.573%Search for SEC Filing on Google Icon
2/13/2026Ieq Capital LLC4,144$0.28M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026Dynamic Technology Lab Private Ltd4,080$0.27M0.1%N/A0.003%Search for SEC Filing on Google Icon
2/13/2026UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC1,260,380$83.68M0.0%-28.4%0.900%Search for SEC Filing on Google Icon
2/13/2026Wells Fargo & Company MN152,507$10.13M0.0%+90.1%0.109%Search for SEC Filing on Google Icon
2/13/2026Platinum Investment Management Ltd.89,484$5.94M1.4%-19.4%0.064%Search for SEC Filing on Google Icon
2/13/2026Rhenman & Partners Asset Management AB144,500$9.59M0.9%N/A0.103%Search for SEC Filing on Google Icon
2/13/2026Keystone Investors PTE Ltd.57,900$3.84M0.3%N/A0.041%Search for SEC Filing on Google Icon
2/13/2026Macquarie Group Ltd.4,182$0.28M0.0%-94.2%0.003%Search for SEC Filing on Google Icon
2/12/2026Brooklyn Investment Group4,808$0.34M0.0%N/A0.003%Search for SEC Filing on Google Icon
2/12/2026MetLife Investment Management LLC73,040$4.85M0.0%+1.5%0.052%Search for SEC Filing on Google Icon
2/12/2026Cibc World Markets Corp8,780$0.58M0.0%N/A0.006%Search for SEC Filing on Google Icon
2/12/2026Commonwealth Equity Services LLC55,673$3.70M0.0%-15.6%0.040%Search for SEC Filing on Google Icon
2/12/2026Dimensional Fund Advisors LP147,412$9.79M0.0%-68.9%0.105%Search for SEC Filing on Google Icon
2/12/2026EntryPoint Capital LLC4,961$0.33M0.1%N/A0.004%Search for SEC Filing on Google Icon
2/12/2026Federated Hermes Inc.676$45K0.0%-55.2%0.000%Search for SEC Filing on Google Icon
2/12/2026Ensign Peak Advisors Inc23,336$1.55M0.0%+8.1%0.017%Search for SEC Filing on Google Icon
2/12/2026Edgewood Management LLC25,000$1.66M0.0%-16.7%0.018%Search for SEC Filing on Google Icon
2/12/2026Marex Group plc4,687$0.31M0.0%N/A0.003%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Arrowhead Pharmaceuticals logo
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes Plozasiran, which is in Phase 2b and one Phase 3 clinical trial to treat hypertriglyceridemia, mixed dyslipidemia, and chylomicronemia syndrome; Zodasiran that is in Phase 2b clinical trial for the treatment of dyslipidemia and hypertriglyceridemia; ARO-PNPLA3, which is in Phase 1 clinical trial to treat patients with non-alcoholic steatohepatitis; ARO-RAGE that is in Phase 1/2a clinical trial to treat inflammatory pulmonary conditions; and ARO-MUC5AC, which is in Phase 1/2a clinical trial to treat muco-obstructive pulmonary diseases. It also develops ARO-MMP7 that is in Phase 1/2a clinical trial for treatment of idiopathic pulmonary fibrosis; ARO-DUX4 for the treatment of facioscapulohumeral muscular dystrophy; ARO-SOD1 for the potential treatment of amyotrophic lateral sclerosis; and ARO-C3, which is in Phase 1/2a clinical trial for the treatment of patients with various complement mediated or complement associated renal diseases. In addition, the company is involved in the development of JNJ-3989, which is in Phase 2 clinical trial to treat chronic hepatitis B virus infection; Olpasiran that is in Phase 3 clinical trial to reduce the production of apolipoprotein A; GSK-4532990 that is in phase 2 clinical trial to treat liver diseases; HZN-457, which is in phase 1 clinical trial to treat uncontrolled gout; and Fazirsiran that is in Phase 3 clinical trial for the treatment for liver disease associated with alpha-1 antitrypsin deficiency. Arrowhead Pharmaceuticals, Inc. has license and research collaboration agreements with Janssen Pharmaceuticals, Inc.; Takeda Pharmaceutical Company Limited; Horizon Therapeutics Ireland DAC; Amgen Inc.; and Glaxosmithkline Intellectual Property (No. 3) Limited. The company was founded in 2003 and is headquartered in Pasadena, California.
Read More on Arrowhead Pharmaceuticals

Today's Range

Now: $56.33
Low: $54.89
High: $58.00

50 Day Range

MA: $63.57
Low: $55.01
High: $73.00

52 Week Range

Now: $56.33
Low: $9.57
High: $76.76

Volume

6,213,799 shs

Average Volume

2,412,752 shs

Market Capitalization

$7.89 billion

P/E Ratio

36.82

Dividend Yield

N/A

Beta

1.23

Who are the company insiders with the largest holdings of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top insider shareholders include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Tracie Oliver (Insider)
  6. Michael S Perry (Director)
  7. Mauro Ferrari (Director)
  8. William D Waddill (Director)
  9. Adeoye Y Olukotun (Director)
  10. Victoria Vakiener (Director)
Learn More about top insider investors at Arrowhead Pharmaceuticals.

Who are the major institutional investors of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals' top institutional shareholders include:
  1. Vanguard Group Inc. — 11.25%
  2. Avoro Capital Advisors LLC — 7.59%
  3. State Street Corp — 4.57%
  4. Geode Capital Management LLC — 2.33%
  5. Baker BROS. Advisors LP — 1.55%
  6. Arrowstreet Capital Limited Partnership — 1.49%
Learn More about top institutional investors of Arrowhead Pharmaceuticals stock.

Which institutional investors are selling Arrowhead Pharmaceuticals stock?

During the last quarter, ARWR stock was sold by these institutional investors:
  1. Marshall Wace LLP
  2. Siren L.L.C.
  3. Vanguard Group Inc.
  4. Schonfeld Strategic Advisors LLC
  5. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
  6. Balyasny Asset Management L.P.
  7. Dimensional Fund Advisors LP
  8. Avoro Capital Advisors LLC
In the last year, company insiders that have sold Arrowhead Pharmaceuticals company stock include:
  1. Christopher Richard Anzalone (CEO)
  2. Patrick O'brien (COO)
  3. Kenneth Allen Myszkowski (CFO)
  4. James C Hamilton (Insider)
  5. Tracie Oliver (Insider)
  6. Michael S Perry (Director)
  7. Mauro Ferrari (Director)
  8. William D Waddill (Director)
Learn More investors selling Arrowhead Pharmaceuticals stock.

Which institutional investors are buying Arrowhead Pharmaceuticals stock?

Within the last quarter, ARWR stock was acquired by institutional investors including:
  1. Norges Bank
  2. Fred Alger Management LLC
  3. Vestal Point Capital LP
  4. Pictet Asset Management Holding SA
  5. Price T Rowe Associates Inc. MD
  6. RTW Investments LP
  7. Adage Capital Partners GP L.L.C.
  8. Baker BROS. Advisors LP